{"id":"W2334272293","doi":"10.1158/1538-7445.am2011-623","title":"Abstract 623: CLU inhibition using OGX-011 is a new adjuvant therapeutic strategy for HSP90 inhibition in prostate cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Clusterin; LNCaP; Cancer research; Prostate cancer; Hsp90 inhibitor; Apoptosis; Cell growth; Biology; In vivo; Hsp90; Cancer; Heat shock protein; Medicine; Internal medicine; Biochemistry","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006936595,0.0002085592,0.0003489814,0.0003691449,0.0001217684,0.00003501499,0.00008112654,0.0001651489,0.002536907],"category_scores_gemma":[0.00006403442,0.0001962777,0.00009790678,0.0005230904,0.0002359456,0.000201505,0.00008860517,0.0005668852,0.00003500579],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008969515,"about_ca_system_score_gemma":0.001716302,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007517961,"about_ca_topic_score_gemma":0.002008107,"domain_scores_codex":[0.9975744,0.0001133696,0.0004319031,0.0005783441,0.000487536,0.0008143747],"domain_scores_gemma":[0.9987536,0.00008049213,0.0001004298,0.0003598777,0.0004131047,0.0002925178],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01018999,0.0008095037,0.02381367,0.002271251,0.0001571469,0.0009035356,0.0113623,0.0002650711,0.8294948,0.0002765833,0.006818855,0.1136373],"study_design_scores_gemma":[0.02061361,0.002306069,0.4145237,0.005861973,0.0002823212,0.0002216187,0.003369863,0.002745153,0.5252684,0.01976384,0.003858398,0.001185111],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9915808,0.003872671,0.000122422,0.001023587,0.0001799126,0.00227125,0.0001698876,0.00004439203,0.0007350174],"genre_scores_gemma":[0.9962995,0.0008362808,0.0002151147,0.0005491956,0.0003743311,0.0009728433,0.00004458698,0.00007250986,0.0006356325],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.39071,"threshold_uncertainty_score":0.9990911,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3489976194467707,"score_gpt":0.4827314625150633,"score_spread":0.1337338430682926,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}